6 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 6 of 6 clinical reviews.
Evidence-based guide to tirzepatide (Mounjaro) dosing considerations for Hispanic and Latino patients, covering pharmacogenomics, metabolic differences, clinical trial subgroup data, and practical titration guidance.
Tirzepatide (Mounjaro) produces measurably different weight loss and glycemic outcomes in East Asian patients due to pharmacogenomic variation, lower BMI thresholds, and body-composition differences. This review covers ethnicity-stratified trial data, CYP variant frequencies, and dosing considerations.
Evidence-based guide to tirzepatide (Mounjaro) dosing considerations for East Asian patients, covering BMI thresholds, pharmacogenomic background, trial evidence, and monitoring.
A clinical deep-dive into tirzepatide (Mounjaro) efficacy differences in Hispanic and Latino patients, covering ethnicity-stratified RCT subgroup data, pharmacogenomics, insulin resistance phenotypes, and dosing considerations.
A clinical review of tirzepatide (Mounjaro) efficacy in Black and African ancestry patients, covering SURPASS trial subgroup data, pharmacogenomic factors, hypertension considerations, and evidence-based dosing guidance.
A clinical deep-dive into tirzepatide (Mounjaro) efficacy differences in South Asian patients: subgroup data, pharmacogenomics, BMI thresholds, and dosing considerations prepared by the HealthRX.com Editorial Team.